We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Says Aspirin Involved in Brilinta Treatment Differences
AstraZeneca Says Aspirin Involved in Brilinta Treatment Differences
January 28, 2011
AstraZeneca has replied to a complete response letter on its blood-thinner Brilinta, providing supplementary analyses of its PLATO trial that focus on interactions between the drug and high-dose aspirin.